Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol protection against exercise-induced inspiratory airflow obstruction in asthmatic children
NL-OMON24513Not yet recruiting
- Sponsor
- Medisch Spectrum Twente
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of salbutamol in asthma and exercise-induced bronchospasm (EIB) (2 arms), sponsored by Medisch Spectrum Twente. Primary endpoint: Protective effect of salbutamol against inspiratory airflow obstruction. Planned start Sep 2013; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
asthmaexercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on NL-OMON24513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24513.